Archives of Industrial Biotechnology

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +1 (629)348-3199

Mini Review - Archives of Industrial Biotechnology (2024) Volume 8, Issue 4

The impact of proteomics on understanding cellular signaling pathways

Jiaxiang Yang*

Department of Biomedical Engineering, The Hong Kong Polytechnic University, Hong Kong, China

*Corresponding Author:
Jiaxiang Yang
Department of Biomedical Engineering
The Hong Kong Polytechnic University
Hong Kong, China
E-mail:ji.yang@polyu.edu.hk

Received: 26-Jul-2024, Manuscript No. AAAIB-24-144208; Editor assigned: 29-Jul-2024, PreQC No. AAAIB-24-144208 (PQ); Reviewed: 09-Aug-2024, QC No. AAAIB-24-144208; Revised: 21-Aug-2024, Manuscript No. AAAIB-24-144208 (R); Published: 27-Aug-2024, DOI: 10.35841/aaaib- 8.4.224

Citation: Yang J. The impact of proteomics on understanding cellular signaling pathways. Arch Ind Biot. 2024; 8(4):224

Visit for more related articles at Archives of Industrial Biotechnology

Proteomics, the large-scale study of proteins, has revolutionized our understanding of cellular signaling pathways. These pathways are crucial for cells to respond to external and internal stimuli, and dysregulation can lead to various diseases, including cancer, diabetes, and neurodegenerative disorders. By elucidating the complex network of proteins and their interactions, proteomics provides comprehensive insights into cellular signaling mechanisms [1], [2]

Proteomics involves the identification and quantification of the complete set of proteins (the proteome) within a cell, tissue, or organism. Advances in mass spectrometry, bioinformatics, and high-throughput techniques have enabled researchers to analyze thousands of proteins simultaneously. This capability is essential for mapping signaling pathways, which often involve numerous proteins interacting in dynamic and context-dependent ways [3].

A core technique in proteomics, MS allows for the precise identification and quantification of proteins. By measuring the mass-to-charge ratio of ionized protein fragments, researchers can determine protein composition and modifications. These arrays enable the parallel analysis of protein-protein interactions, post-translational modifications, and activity levels. They are particularly useful for studying signaling networks and their changes under different conditions. Techniques such as SILAC (Stable Isotope Labeling by Amino acids in Cell culture) and iTRAQ (Isobaric Tags for Relative and Absolute Quantitation) facilitate the comparison of protein levels across different samples, providing insights into how signaling pathways are regulated. Cellular signaling pathways involve a series of biochemical events initiated by the interaction of a cell with a signaling molecule (ligand). This interaction triggers a cascade of molecular events, often involving phosphorylation and dephosphorylation of proteins, ultimately leading to a cellular response. RTKs play a critical role in regulating cell growth and differentiation. Proteomic studies have identified numerous downstream effectors and cross-talk with other pathways, enhancing our understanding of RTK signaling dynamics. GPCRs are involved in a wide range of physiological processes. Proteomics has uncovered the diversity of GPCR signaling complexes and their context-specific responses, shedding light on their roles in health and disease. This pathway is crucial for cell proliferation and survival. Proteomic analyses have detailed the temporal and spatial dynamics of MAPK/ERK signaling, revealing how specific protein interactions and modifications regulate the pathway. Important for cell metabolism and growth, this pathway is frequently dysregulated in cancer. Proteomics has identified novel components and regulatory mechanisms, offering potential therapeutic targets [4], [5]

By comparing the proteomes of healthy and cancerous tissues, researchers have identified key signaling proteins and pathways involved in tumorigenesis, metastasis, and resistance to therapy. This knowledge facilitates the development of targeted treatments. Proteomic studies have revealed changes in signaling pathways in conditions such as Alzheimer's and Parkinson's disease, highlighting potential biomarkers and therapeutic targets. Insights into insulin signaling and glucose metabolism from proteomic analyses have advanced our understanding of diabetes and obesity, paving the way for novel therapeutic approaches [6], [7]

Despite its successes, proteomics faces several challenges. The complexity of the proteome, with its vast diversity and dynamic range, requires continuous technological advancements. Data integration from multiple omics platforms is essential for a holistic understanding of cellular signaling. Future directions in proteomics include the development of single-cell proteomics, which will allow the study of signaling pathways at unprecedented resolution. Advances in bioinformatics and machine learning will further enhance the analysis and interpretation of complex proteomic data [8], [9]

Proteomics has profoundly impacted our understanding of cellular signaling pathways, providing detailed insights into the molecular mechanisms underlying cellular responses. These advances not only enhance our fundamental knowledge but also drive the development of novel therapeutic strategies for various diseases. As proteomic technologies continue to evolve, their contribution to biomedical research will undoubtedly expand, offering new horizons in the study of cellular signalling [10].

References

  1. Griendling KK, Camargo LL, Rios FJ, et al. Oxidative stress and hypertension. Circ Res. 2021;128(7):993-1020.

    2. Google Scholar

  2. Cao L, Huang C, Zhou DC, et al. Proteogenomic characterization of pancreatic ductal adenocarcinoma. Cell. 2021;184(19):5031-52.

    3. Indexed at, Google Scholar, Cross Ref

  3. Martínez-Rodríguez F, Limones-González JE, Mendoza-Almanza B, et al. Understanding cervical cancer through proteomics. Cells. 2021;10(8):1854.

    4. Indexed at, Google Scholar, Cross Ref

  4. Kim TW, Park CH, Hsu CC, et al. Mapping the signaling network of BIN2 kinase using TurboID-mediated biotin labeling and phosphoproteomics. Plant Cell. 2023;35(3):975-93.

    5. Indexed at, Google Scholar, Cross Ref

  5. Weidemuller P, Kholmatov M, Petsalaki E, et al. Transcription factors: Bridge between cell signaling and gene regulation. Proteomics. 2021;21(23-24):2000034.

    6. Indexed at, Google Scholar, Cross Ref

  6. Goos H, Kinnunen M, Salokas K, et al. Human transcription factor protein interaction networks. Nat Commun. 2022;13(1):766.

    7. Indexed at, Google Scholar, Cross Ref

  7. Kaufmann M, Schaupp AL, Sun R, et al. Identification of early neurodegenerative pathways in progressive multiple sclerosis. Nat Neurosci. 2022;25(7):944-55.

    8. Indexed at, Google Scholar, Cross Ref

  8. Martinelli S, Anderzhanova EA, Bajaj T, et al. Stress-primed secretory autophagy promotes extracellular BDNF maturation by enhancing MMP9 secretion. Nature Commun. 2021;12(1):4643.

    9. Indexed at, Google Scholar, Cross Ref

  9. Cheng J, Tao J, Li B, et al. Swine influenza virus triggers ferroptosis in A549 cells to enhance virus replication. Virol J. 2022;19(1):104.

    10. Indexed at, Google Scholar, Cross Ref

  10. Liu Z, Liu Y, Qian L, et al. A proteomic and phosphoproteomic landscape of KRAS mutant cancers identifies combination therapies. Mol Cell. 2021;81(19):4076-90.

    11. Indexed at, Google Scholar, Cross Ref

Get the App